A Clinical trial study the effect of Rasa chendhuram in patients with vitiligo
Phase 2
- Conditions
- Health Condition 1: null- VENPULLI(VITILIGO)
- Registration Number
- CTRI/2017/07/008969
- Lead Sponsor
- Dr R Kalaimani
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 40
Inclusion Criteria
1.Hypo-pigmented patches with hyper pigmented border without any structural changes in any part of the body.
2.Patient willing to sign consent form.
Exclusion Criteria
Albinism
Leprosy
STD
1.HIV
2.Burns
3.Pregnant women and Lactating mothers
4.Cardiac diseases
5.History of long term use of steroids.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The therapeutic efficacy of trial drugs will be assessed by repigmentation and also by reduction in the size of â??VASIâ?? Score (Vitiligo area scoring index) <br/ ><br> <br/ ><br>Timepoint: 12months <br/ ><br> <br/ ><br>
- Secondary Outcome Measures
Name Time Method The safety of the trial drugs is measuredTimepoint: 12months